AMD to take equity stake in PsiQuantum as the two co-design utility-scale quantum infrastructure
The expanded partnership adds AMD Instinct GPUs, EPYC CPUs and ROCm to PsiQuantum's existing use of Versal FPGAs, starts with drug-discovery work and may extend to Chicago's Illinois Quantum and Microelectronics Park; the investment size was not disclosed.
Why it matters
Fault-tolerant quantum computers need large amounts of conventional computing for control, simulation and real-time error correction, and this deal puts AMD's CPUs, GPUs and software into that role at PsiQuantum. The companies say they have already optimised a machine-learning decoder, PRISM, for low-latency error correction on AMD accelerators. Finimize notes the US Commerce Department said in May it planned a $100 million stake in PsiQuantum under a $2 billion CHIPS Act programme. More details are due at SC26 in Chicago, 15 to 20 November.
Key facts
- Announced 12 Nov 2026
- AMD plans an equity investment; size not disclosed
- Adds Instinct GPUs, EPYC CPUs and ROCm to existing Versal FPGA work
- PRISM machine-learning decoder optimised for real-time error correction
- Initial focus: drug discovery
- More at SC26, Chicago, 15–20 Nov